"Academic Incubator" to develop new medicines of value
01 September 2008GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.
Research
GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.
Many UK manufacturers have transferred their production to low-cost regions to reduce costs. But a new study has discovered that these savings are not as...
A magnificent new collection at the University Library makes Cambridge a major international centre for Montaigne scholarship.
Medical devices created by a spin-out company from the University of Cambridge are helping the body to heal itself.
Current estimates suggest that a language dies every two weeks. Here, Geoffrey Khan describes the documentation of a group of dialects before they are lost...
A unique model of industrial-academic partnership is demonstrating how UK R&D can stay ahead of the game in a rapidly moving electronics market.
New research shows that it's not just having conversations with children that matter, it's the quality of the content.
Medical imaging in Cambridge is pushing the boundaries in diagnosis and therapy as well as helping scientists within their own disciplines.
Why does one violin sound different to another? Investigating this question has brought together researchers from music, engineering, experimental psychology and computer science.
A prolific writer and champion of accessible philosophy, Simon Blackburn was honoured this year by the prestigious American Academy of Arts and Sciences for his...